These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10732663

  • 1. Lack of desipramine toxicity with citalopram.
    Ashton AK.
    J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
    [No Abstract] [Full Text] [Related]

  • 2. Managing rapid metabolizers of antidepressants.
    Kraus RP, Diaz P, McEachran A.
    Depress Anxiety; 2000 Feb; 4(6):320-7. PubMed ID: 9166660
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P, Bondolfi G, Eap CB, Macciardi F, Baumann P.
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [Abstract] [Full Text] [Related]

  • 4. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E, Vandel P, Broly F, Vandel S, Sechter D, Bizouard P, Bechtel PR.
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [Abstract] [Full Text] [Related]

  • 5. Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.
    Preskorn SH, Nichols AI, Paul J, Patroneva AL, Helzner EC, Guico-Pabia CJ.
    J Psychiatr Pract; 2008 Nov; 14(6):368-78. PubMed ID: 19057238
    [Abstract] [Full Text] [Related]

  • 6. Anticholinergic toxic syndrome with venlafaxine-desipramine combination.
    Benazzi F.
    Pharmacopsychiatry; 1998 Jan; 31(1):36-7. PubMed ID: 9524985
    [No Abstract] [Full Text] [Related]

  • 7. Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
    Baumann P, Broly F, Kosel M, Eap CB.
    Pharmacopsychiatry; 1998 Mar; 31(2):72. PubMed ID: 9562213
    [No Abstract] [Full Text] [Related]

  • 8. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
    Reese MJ, Wurm RM, Muir KT, Generaux GT, St John-Williams L, McConn DJ.
    Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK, McKenzie J, Worrall N.
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P, Haffen E, Nezelof S, Broly F, Kantelip JP, Sechter D.
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [Abstract] [Full Text] [Related]

  • 13. Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
    Alderman J, Preskorn SH, Greenblatt DJ, Harrison W, Penenberg D, Allison J, Chung M.
    J Clin Psychopharmacol; 1997 Aug; 17(4):284-91. PubMed ID: 9241008
    [Abstract] [Full Text] [Related]

  • 14. Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction.
    Hefner G, Geschke K, Hiemke C.
    J Clin Psychopharmacol; 2014 Jun; 34(3):394-6. PubMed ID: 24743723
    [No Abstract] [Full Text] [Related]

  • 15. Genetics in pharmacokinetics?
    Hartter S.
    Am J Psychiatry; 2004 Jul; 161(7):1308-9; author reply 1309. PubMed ID: 15229072
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rates of in vivo methylation of desipramine and nortriptyline.
    Kurpius MP, Alexander B.
    Pharmacotherapy; 2006 Apr; 26(4):505-10. PubMed ID: 16553509
    [Abstract] [Full Text] [Related]

  • 20. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG, Nolen WA.
    Tijdschr Psychiatr; 2006 Apr; 48(5):405-8. PubMed ID: 16956033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.